AUSTIN, Texas–(BUSINESS WIRE) September 18, 2026 –IntraBio Inc., a leader in the discovery, development, and commercialization of novel therapies for rare and common neurodegenerative diseases, today announced that the U.S. Food and Drug…
Source: Read More